Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth provider agreed to sell Novo’s branded medicines. “We’ve decided to drop the court proceedings and don’t expect to revisit them,” CEO Mike Doustdar told CNBC. #novonordisk #glp1 #weightloss #cnbc